Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Tang

Showing results (1621-1630 of 1,661) with videos related to

Pageof 167
Sort By:
Nature Cancer|August 3, 2023
Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissuesPengle Yao, Peng Xiao, Zongyao Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Magnetically actuated microrobotic system for sequential treatment of biofilmShunyao Li, Yu Mei, Kai Xu, et al.
Oncotarget|October 30, 2016
Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expressionChih-Min Tang, Tracy E Lee, Sabriya A Syed, et al.
Blood|July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Journal of Hematology & Oncology|June 1, 2018
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathwaysXiaolan Lian, Yu-Min Lin, Shingo Kozono, et al.
Journal of Veterinary Internal Medicine|October 6, 2023
Novel genomic prognostic biomarkers for dogs with cancerEsther Chon, Sharadha Sakthikumar, Min Tang, et al.
Archives of Virology|March 9, 2019
Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonatesTing-Ting Peng, Qiu-E Cai, Min Yang, et al.
Journal of Hematology & Oncology|July 13, 2018
Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathwaysXiaolan Lian, Yu-Min Lin, Shingo Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoringJiayao Ni, Yi Sun, Hao Cheng, et al.
Oncotarget|July 24, 2015
miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinomaLuqing Zhao, Min Tang, Zheyu Hu, et al.
Pageof 167

Showing results (1621-1630 of 1,661) with videos related to

Sort By:
Pageof 167
Nature Cancer|August 3, 2023
Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissuesPengle Yao, Peng Xiao, Zongyao Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 6, 2026
Magnetically actuated microrobotic system for sequential treatment of biofilmShunyao Li, Yu Mei, Kai Xu, et al.
Oncotarget|October 30, 2016
Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expressionChih-Min Tang, Tracy E Lee, Sabriya A Syed, et al.
Blood|July 24, 2024
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan-Inge Henter, Elena Sieni, Julia Eriksson, et al.
Journal of Hematology & Oncology|June 1, 2018
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathwaysXiaolan Lian, Yu-Min Lin, Shingo Kozono, et al.
Journal of Veterinary Internal Medicine|October 6, 2023
Novel genomic prognostic biomarkers for dogs with cancerEsther Chon, Sharadha Sakthikumar, Min Tang, et al.
Archives of Virology|March 9, 2019
Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonatesTing-Ting Peng, Qiu-E Cai, Min Yang, et al.
Journal of Hematology & Oncology|July 13, 2018
Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathwaysXiaolan Lian, Yu-Min Lin, Shingo Kozono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoringJiayao Ni, Yi Sun, Hao Cheng, et al.
Oncotarget|July 24, 2015
miR-504 mediated down-regulation of nuclear respiratory factor 1 leads to radio-resistance in nasopharyngeal carcinomaLuqing Zhao, Min Tang, Zheyu Hu, et al.
Pageof 167